Saturday 17 October 2026
Export GKOS’s income statement to Excel — free account
Glaukos Corporation
GKOS Healthcare Medical Devices
Glaukos Corporation’s revenue for fiscal 2025 (year ended December 2025) was $507.4 million, up 32.3% from fiscal 2024. In the quarter to June 2026, revenue grew 49.5%, EPS grew 8.82%, free cash flow grew 211.8% and total debt fell 2.15%, each against the same quarter a year earlier. Revenue growth for three consecutive years.
164.84
0.76
−0.46%
Follow GKOS
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 | Dec '20 | Dec '19 | Dec '18 | Dec '17 | Dec '16 | |
|---|---|---|---|---|---|---|---|---|---|---|
P/E ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 160.21 | 0.00 | 0.00 | 253.15 |
Piotroski F-Score |
3 | 4 | 3 | 1 | 5 | 2 | 2 | 4 | 5 | 7 |
P/S ratio |
12.73 | 20.63 | 11.86 | 7.36 | 7.02 | 14.89 | 8.59 | 10.94 | 5.85 | 9.71 |
Altman Z-Score |
15.20 | 22.21 | 4.23 | 2.44 | 2.85 | 5.83 | 8.48 | 36.08 | 19.33 | 39.51 |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 232.05 | 47.07 | 184.10 |
Altman Z″-Score (non-manufacturers) |
0.74 | 3.06 | 0.26 | 1.55 | 2.63 | 2.98 | 5.35 | 6.49 | 6.23 | 7.79 |
Beneish M-Score |
(2.96) | (2.26) | (2.79) | (2.73) | (2.90) | (3.28) | 2.81 | (2.64) | (3.28) | (2.05) |
P/Operating CF |
943.64 | 15,601.75 | (350.04) | (503.35) | (443.57) | 315.81 | (485.50) | 115.82 | 74.71 | 338.72 |
P/B ratio |
9.84 | 10.31 | 8.08 | 3.93 | 3.51 | 5.02 | 3.02 | 11.41 | 6.74 | 9.47 |
Price to Tangible BV |
14.43 | 18.09 | 33.13 | 13.35 | 10.96 | 13.75 | 9.06 | 11.44 | 6.89 | 10.03 |
EV/Sales |
12.86 | 20.71 | 12.93 | 8.35 | 7.76 | 14.21 | 8.11 | 10.19 | 5.12 | 8.90 |
EV/EBITDA |
0.00 | 0.00 | 0.00 | 0.00 | 577.48 | 0.00 | 0.00 | 0.00 | 253.28 | 111.01 |
EV/Operating CF |
(441.27) | (129.49) | (70.47) | (71.40) | 92.32 | (139.01) | (5,206.45) | 97.92 | 31.27 | 82.73 |
EV/FCF |
(167.07) | (117.49) | (52.18) | (37.38) | (98.86) | (106.79) | (377.22) | 216.06 | 41.25 | 168.84 |
Quick Ratio |
3.82 | 5.05 | 4.53 | 5.37 | 7.06 | 8.86 | 3.68 | 5.24 | 5.06 | 6.50 |
Current Ratio |
4.69 | 5.99 | 5.34 | 6.13 | 7.67 | 9.45 | 4.56 | 5.81 | 5.58 | 7.09 |
Net Debt/EBITDA |
1.31 | 2.91 | (0.64) | (0.02) | (15.53) | 2.67 | 3.14 | 19.98 | (36.95) | (10.45) |
Debt/Assets |
7.62% | 7.13% | 37.57% | 35.27% | 33.60% | 24.87% | 7.14% | 0.00% | 0.00% | 0.00% |
Debt/Equity |
0.10 | 0.09 | 0.77 | 0.67 | 0.60 | 0.37 | 0.09 | 0.00 | 0.00 | 0.00 |
Asset Turnover |
0.54 | 0.40 | 0.32 | 0.28 | 0.29 | 0.25 | 0.46 | 0.97 | 1.06 | 0.91 |
Operating CF/Net income |
0.08 | 0.42 | 0.43 | 0.33 | (0.50) | 0.19 | (0.02) | (1.46) | (283.60) | 2.72 |
Capex/Depreciation |
(0.62) | (0.17) | (0.54) | (0.79) | (1.30) | (0.11) | (0.35) | (1.73) | (1.15) | (1.27) |
Interest Coverage |
(43.06) | (12.19) | (9.44) | (6.00) | (2.46) | (8.75) | (19.61) | (5.77) | (1.66) | 4.77 |
| (26.38%) | (23.83%) | (27.16%) | (17.76%) | (7.91%) | (17.95%) | 3.64% | (8.30%) | (0.07%) | 4.26% | |
| (20.09%) | (15.29%) | (13.86%) | (9.67%) | (4.83%) | (13.20%) | 3.01% | (6.95%) | (0.06%) | 3.60% | |
ROIC |
(28.00%) | (14.78%) | (15.48%) | (9.69%) | (3.91%) | (15.05%) | (5.64%) | (24.35%) | (7.43%) | 12.37% |
Return on Tangible Assets |
(38.54%) | (30.98%) | (31.71%) | (21.29%) | (10.09%) | (27.12%) | 6.79% | (7.83%) | (0.07%) | 4.09% |
Average Days of Receivables |
78.12 | 57.82 | 46.22 | 46.55 | 41.51 | 58.51 | 59.17 | 37.60 | 38.17 | 45.64 |
Research and Development Expense of Revenue |
29.68% | 39.29% | 45.68% | 47.12% | 34.35% | 37.96% | 28.82% | 27.40% | 24.43% | 25.55% |
Selling, General and Administrative Expense of Revenue |
65.38% | 68.10% | 71.20% | 68.20% | 60.97% | 76.19% | 74.53% | 65.94% | 60.44% | 56.61% |
Intangible Assets out of Total Assets |
0.23 | 0.34 | 0.37 | 0.37 | 0.38 | 0.42 | 0.55 | 0.00 | 0.02 | 0.05 |
Share Based Compensation of Revenue |
12.46% | 13.09% | 13.83% | 13.63% | 10.25% | 20.66% | 15.36% | 14.18% | 11.05% | 7.68% |
Graham Net Nets |
0.04 | 0.03 | (0.02) | (0.01) | 0.01 | 0.04 | 0.06 | 0.07 | 0.13 | 0.09 |
Graham Number |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 11.74 | 0.00 | 0.00 | 3.27 |
Earnings Yield |
(2.89%) | (1.91%) | (3.61%) | (4.76%) | (2.43%) | (3.63%) | 0.62% | (0.66%) | 0.00% | 0.40% |
Free Cash Flow Yield |
(0.60%) | (0.85%) | (2.09%) | (3.04%) | (1.12%) | (0.89%) | (0.25%) | 0.43% | 2.12% | 0.54% |
Revenue per Share |
8.87 | 7.27 | 6.50 | 5.96 | 6.33 | 5.06 | 6.34 | 5.13 | 4.63 | 3.47 |
Operating CF per Share |
(0.26) | (1.16) | (1.19) | (0.70) | 0.53 | (0.52) | (0.01) | 0.53 | 0.76 | 0.37 |
Capex per Share |
(0.42) | (0.12) | (0.42) | (0.63) | (1.03) | (0.16) | (0.13) | (0.29) | (0.18) | (0.19) |
Free Cash Flow per Share |
(0.68) | (1.28) | (1.61) | (1.33) | (0.50) | (0.67) | (0.14) | 0.24 | 0.58 | 0.18 |
Cash per Share |
4.87 | 6.05 | 6.10 | 7.43 | 8.92 | 9.09 | 4.66 | 3.98 | 3.46 | 2.91 |
Shareholders Equity per Share |
11.47 | 14.54 | 9.53 | 11.17 | 12.65 | 15.00 | 18.02 | 4.92 | 4.02 | 3.56 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
11.47 | 14.54 | 9.53 | 11.17 | 12.65 | 15.00 | 18.02 | 4.92 | 4.02 | 3.56 |
Free Cash Flow |
(39.06) | (67.58) | (78.01) | (63.20) | (23.07) | (29.92) | (5.09) | 8.55 | 19.78 | 6.03 |
Working Capital |
373.71 | 374.67 | 321.45 | 371.50 | 422.77 | 419.74 | 205.18 | 146.20 | 122.67 | 103.09 |
Capital Expenditures |
(24.27) | (6.26) | (20.25) | (30.11) | (47.78) | (6.93) | (4.72) | (10.31) | (6.31) | (6.28) |
Net Current Asset Value |
237.65 | 241.97 | (83.19) | (28.52) | 23.58 | 131.39 | 117.75 | 143.46 | 121.83 | 102.93 |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 240.11 |
Capex to Sales |
0.05 | 0.02 | 0.06 | 0.11 | 0.16 | 0.03 | 0.02 | 0.06 | 0.04 | 0.05 |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 261.81 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
0.35 | 0.37 | 0.36 | 0.40 | 0.53 | 2.74 | 0.61 | 0.31 | 0.47 | 0.65 |
Cash ROIC |
(3.89%) | (5.85%) | (7.02%) | (5.11%) | (1.70%) | (2.26%) | (0.56%) | 2.72% | 7.69% | 2.83% |
Accounts Receivable Turnover |
5.99 | 7.62 | 8.29 | 8.14 | 8.46 | 6.04 | 8.30 | 10.26 | 10.29 | 10.47 |
Accounts Payable Turnover |
5.94 | 7.11 | 5.43 | 6.35 | 11.39 | 18.07 | 6.40 | 4.00 | 4.57 | 4.91 |
Inventory Turnover |
1.84 | 1.89 | 1.89 | 2.27 | 3.43 | 3.14 | 1.38 | 2.05 | 2.33 | 2.96 |
Average Days of Payables |
80.38 | 50.57 | 64.91 | 76.21 | 40.17 | 17.39 | 54.68 | 91.50 | 108.27 | 66.94 |
Days of Inventory on Hand |
207.50 | 223.90 | 202.78 | 200.23 | 126.06 | 62.91 | 402.74 | 193.34 | 194.59 | 154.42 |
Average Receivables |
84.68 | 50.30 | 37.96 | 34.76 | 34.75 | 37.24 | 28.55 | 17.66 | 15.48 | 10.93 |
Average Payables |
18.83 | 13.23 | 13.92 | 10.87 | 5.85 | 5.08 | 6.03 | 6.27 | 4.61 | 3.30 |
Average Inventory |
60.62 | 49.83 | 39.91 | 30.43 | 19.41 | 29.19 | 27.93 | 12.25 | 9.03 | 5.47 |
Average Assets |
934.12 | 957.59 | 971.40 | 1,026.04 | 1,027.60 | 911.95 | 512.69 | 186.40 | 150.10 | 125.52 |
Average Common Equity |
711.54 | 614.35 | 495.89 | 558.58 | 627.30 | 670.36 | 423.57 | 156.03 | 127.74 | 106.23 |
Columns are period end dates